NUTRA PHARMA CORP. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
NUTRA PHARMA CORP. (NPHC) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $443.28 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-05-20.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-05-20
- NUTRA PHARMA CORP. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $443.28K, a 78.07% decline from fiscal 2024.
- NUTRA PHARMA CORP. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $2.02M, a 561.52% increase from fiscal 2023.
- NUTRA PHARMA CORP. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $305.54K, a 57.65% decline from fiscal 2022.
- NUTRA PHARMA CORP. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $721.42K, a 34.67% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $443.28K 10-K · filed 2026-05-20 | |
| 2024-12-31 | $2.02M 10-K · filed 2026-05-20 | |
| 2023-12-31 | $305.54K 10-K · filed 2026-02-17 | |
| 2022-12-31 | $721.42K 10-K · filed 2025-11-24 | |
| 2021-12-31 | $535.69K 10-K · filed 2025-09-03 | |
| 2020-12-31 | $340.62K 10-K · filed 2022-04-15 | |
| 2019-12-31 | $356.60K 10-K · filed 2021-09-08 | |
| 2018-12-31 | $3.75M 10-K · filed 2021-07-01 | -$3.75M 10-K · filed 2021-02-05 |
| 2017-12-31 | $803.56K 10-K · filed 2021-02-05 | $803.00K 10-K · filed 2018-04-17 |
| 2016-12-31 | $649.00K 10-K · filed 2018-04-17 | |
| 2015-12-31 | $207.00K 10-K · filed 2017-04-17 | |
| 2014-12-31 | $155.00K 10-K · filed 2016-04-14 |